Behavioral disturbances in Alzheimer's disease: A non-pharmacological therapeutic approach

被引:0
|
作者
Silvestri, A
Rosano, G
Zannino, G
Ricca, F
Marigliano, V
Fini, M
机构
[1] TOSINVEST San, Res Unit, Dept Med Sci, I-00163 Rome, Italy
[2] Univ Roma La Sapienza, Sci Invecchiamento Dept, I-00185 Rome, Italy
关键词
Alzheimer disease; behavioral disturbances; empirical behavioral pathology in Alzheimer disease (E-Behave-AD);
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Behavioral disturbances in patients with dementia are among the primary causes of institutionalization. Although the majority of authors agree that such symptoms are well-controlled with non-pharmacological support, almost all studies have been focused on symptomatic drug therapy (typical or atypical neuroleptics). The aim of our study was to evaluate the reduction of psychiatric symptoms revealed with the test called empirical behavioral pathology in Alzheimer disease (E-Behave-AD) in a population of patients with AD whose caregivers underwent training to learn various communication strategies to utilize with family members. We evaluated 35 patients with AD (18 males, 17 females, average age 76.5 +/- 5.9 years). Of these patients, 18 (9 males, 9 females, average age 75.1 +/- 6.5 years) were relatives of caregivers who underwent training for six months, four group-meetings and two individual ones. During the training, caregivers learned about the possibility of communication With persons with AD. They were taught how to interact with the AD patients in various phases of the illness and how to utilize effectively both verbal and non-verbal language. Other 17 patients (9 males, 8 females, average age 76.1 +/- 4.9 years) were followed as a control group. During the period of observation, all patients were given rivastigmine or donezepil. The two groups were homogenous for age, sex, antipsychotic drug therapy, and initial scores on mini-mental state examination (MMSE), activity of daily living (ADL), instrumental activity of daily living (IADL), and E-Behave-AD. After six months, we evaluated the patients with an analogous battery of tests. The analysis of data proceeded from the verification of homogeneity of test subjects and of the control group 2 with t-test for non-paired data. We used the X statistics to compare the qualitative variables between test subjects and the control group. For all statistical tests, a p < 0.05 was considered significant. In the group of patients with caregivers who underwent training, a statistically significant decrease in the E-Behave-AD score (p < 0.001) was observed after six months (7.7 vs. 10.5; p < 0.001). There was no statistically significant modification in the scores for the ADL, IADL, and MMSE (ADL 4.7 vs. 4.3, p = 0.09; IADL 3.2 vs. 3.1, p = 0.4; MMSE 17.3 vs. 15.1, p = 0.1). Numerous evidences in literature underline the centrality of the language deficit in dementia, particularly in AD. A re-establishment, even if partial, of the channels of communication between AD patients and doctors, as well as between patients and caregivers, can reduce the frequency and intensity of behavioral disturbances in persons with AD.
引用
收藏
页码:379 / 386
页数:8
相关论文
共 50 条
  • [1] Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer's disease
    Javed, Binish
    Javed, Amaan
    Kow, Chia Siang
    Hasan, Syed Shahzad
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2023, : 501 - 514
  • [2] Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer's Disease
    Huynh, Quy-Susan
    Elangovan, Shalini
    Holsinger, R. M. Damian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [3] Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease
    Zec, Ronald F.
    Burkett, Nicole R.
    NEUROREHABILITATION, 2008, 23 (05) : 425 - 438
  • [4] Pharmacological treatment in behavioral disturbances in Alzheimer's disease
    Suarez Gomez, M.
    Farinha, S.
    Barbosa, P.
    Isaac, J.
    Moura, P.
    Matos-Pires, A.
    Colaco, P.
    Caeiro, L.
    EUROPEAN PSYCHIATRY, 2019, 56 : S177 - S177
  • [5] Non-pharmacological treatment of Alzheimer's disease: an update
    Wang, Shaofen
    Xu, Haochen
    Liu, Guangdong
    Chen, Limei
    FRONTIERS IN AGING NEUROSCIENCE, 2025, 17
  • [6] Pharmacological management of behavioral disturbances in patients with Alzheimer's disease
    Nagata, Tomoyuki
    Shinagawa, Shunichiro
    Nakajima, Shinichiro
    Noda, Yoshihiro
    Mimura, Masaru
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) : 1093 - 1102
  • [7] A brief essay on non-pharmacological treatment of Alzheimer's disease
    Raggi, Alberto
    Tasca, Domenica
    Ferri, Raffaele
    REVIEWS IN THE NEUROSCIENCES, 2017, 28 (06) : 587 - 597
  • [8] Pharmacological and non-pharmacological management of sleep disturbances in Parkinson's disease: if when and how
    Falup-Pecurariu, Cristian
    Muntean, Maria-Lucia
    Ungureanu, Larisa
    Murasan, Iulia
    Poplawska-Domaszewicz, Karolina
    Chaudhuri, Kallol Ray
    Diaconu, Stefania
    EXPERT OPINION ON PHARMACOTHERAPY, 2024,
  • [9] Management of behavioral and psychological disturbances of Dementia - Pharmacological and non-pharmacological methods.
    Nemlekar, Saumitra
    Srivastava, Ashish
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 : S156 - S156
  • [10] Animal-Assisted Therapy as a Non-Pharmacological Approach in Alzheimer's Disease: A Retrospective Study
    Santaniello, Antonio
    Garzillo, Susanne
    Amato, Alessia
    Sansone, Mario
    Di Palma, Annalisa
    Di Maggio, Annamaria
    Fioretti, Alessandro
    Menna, Lucia Francesca
    ANIMALS, 2020, 10 (07): : 1 - 10